Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immune cartography of macrophage activation syndrome in the COVID-19 era
Dennis McGonagle, Athimalaipet V Ramanan, Charlie Bridgewood
Nature Reviews Rheumatology (2021) Vol. 17, Iss. 3, pp. 145-157
Open Access | Times Cited: 100

Showing 1-25 of 100 citing articles:

Effect of anakinra on mortality in patients with COVID-19: a systematic review and patient-level meta-analysis
Evdoxia Kyriazopoulou, Thomas Huet, Giulio Cavalli, et al.
The Lancet Rheumatology (2021) Vol. 3, Iss. 10, pp. e690-e697
Open Access | Times Cited: 152
COVID-19 and cellular senescence
Clemens A. Schmitt, Tamar Tchkonia, Laura J. Niedernhofer, et al.
Nature reviews. Immunology (2022) Vol. 23, Iss. 4, pp. 251-263
Open Access | Times Cited: 103
The mechanism underlying extrapulmonary complications of the coronavirus disease 2019 and its therapeutic implication
Qin Ning, Di Wu, Xiaojing Wang, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 70
Recent advances and evolving concepts in Still’s disease
Piero Ruscitti, Luca Cantarini, Peter A. Nigrović, et al.
Nature Reviews Rheumatology (2024) Vol. 20, Iss. 2, pp. 116-132
Closed Access | Times Cited: 27
Effects of β-Blockers on the Sympathetic and Cytokines Storms in Covid-19
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Gomaa Mostafa‐Hedeab, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 56
The Immunological Impact of IL-1 Family Cytokines on the Epidermal Barrier
Tom Macleod, Anna Berekméri, Charlie Bridgewood, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 48
A BMP-2–triggered in vivo osteo-organoid for cell therapy
Kai Dai, Qinghao Zhang, Shunshu Deng, et al.
Science Advances (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 20
Multisystem inflammatory syndrome in children (MIS-C): Implications for long COVID
Tamás Constantin, Tamás Pék, Zsuzsanna Horváth, et al.
Inflammopharmacology (2023) Vol. 31, Iss. 5, pp. 2221-2236
Open Access | Times Cited: 18
Extracellular Vesicle‐Inspired Therapeutic Strategies for the COVID‐19
Ziwei Hu, Wei Wang, Ying Lin, et al.
Advanced Healthcare Materials (2024) Vol. 13, Iss. 29
Closed Access | Times Cited: 7
Immunopathology of and potential therapeutics for secondary hemophagocytic lymphohistiocytosis/macrophage activation syndrome: a translational perspective
Tram Nguyen, Yoon Tae Kim, Geunyeol Jeong, et al.
Experimental & Molecular Medicine (2024) Vol. 56, Iss. 3, pp. 559-569
Open Access | Times Cited: 6
Interleukin-18 Is a Potential Biomarker to Discriminate Active Adult-Onset Still’s Disease From COVID-19
Po‐Ku Chen, Joung‐Liang Lan, Po‐Hao Huang, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 40
mTORC1 links pathology in experimental models of Still’s disease and macrophage activation syndrome
Zhengping Huang, Xiaomeng You, Liang Chen, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 25
Type I interferon signature and cycling lymphocytes in macrophage activation syndrome
Zhengping Huang, Kailey Brodeur, Liang Chen, et al.
Journal of Clinical Investigation (2023) Vol. 133, Iss. 22
Open Access | Times Cited: 14
Tailoring the treatment of inflammatory rheumatic diseases by a better stratification and characterization of the clinical patient heterogeneity. Findings from a systematic literature review and experts' consensus
Piero Ruscitti, Yannick Allanore, Chiara Baldini, et al.
Autoimmunity Reviews (2024) Vol. 23, Iss. 7-8, pp. 103581-103581
Closed Access | Times Cited: 5
COVID-19 is Associated with an Increased Risk of Immune Related Thrombocytopenic Disorders: A Large-Scale, Propensity-Matched Global Retrospective Cohort Study
D P Yin, Zhe Chen, Ketian Li, et al.
(2025)
Closed Access
Effector CD8 T cell differentiation in primary and breakthrough SARS-CoV-2 infection in mice
Brock Kingstad-Bakke, Woojong Lee, Boyd L. Yount, et al.
Communications Biology (2025) Vol. 8, Iss. 1
Open Access
Arterial and Venous Thrombosis Complicated in COVID-19: A Retrospective Single Center Analysis in Japan
Seiya Oba, Tadashi Hosoya, Miki Amamiya, et al.
Frontiers in Cardiovascular Medicine (2021) Vol. 8
Open Access | Times Cited: 32
Current and emerging biological therapy in adult-onset Still’s disease
Yuning Ma, Jianfen Meng, Jinchao Jia, et al.
Lara D. Veeken (2021) Vol. 60, Iss. 9, pp. 3986-4000
Open Access | Times Cited: 30
Testosterone in COVID-19: An Adversary Bane or Comrade Boon
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Hani Faidah, et al.
Frontiers in Cellular and Infection Microbiology (2021) Vol. 11
Open Access | Times Cited: 29
Mixed storm in SARS‐CoV‐2 infection: A narrative review and new term in the Covid‐19 era
Basil Mohammed Alomair, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Immunity Inflammation and Disease (2023) Vol. 11, Iss. 4
Open Access | Times Cited: 11
The Systemic Score May Identify Life‐Threatening Evolution in Still Disease: Data from the GIRRCS AOSD‐Study Group and the AIDA Network Still Disease Registry
Piero Ruscitti, Francesco Masedu, Antonio Vitale, et al.
Arthritis & Rheumatology (2024) Vol. 76, Iss. 7, pp. 1141-1152
Closed Access | Times Cited: 4
Neutrophils and COVID-19
Jasmin Šutković
Progress in molecular biology and translational science (2025)
Closed Access
Aging shapes infection profiles of influenza A virus and SARS-CoV-2 in human precision-cut lung slices
Melanie Brügger, Carlos Machahua, Trix Zumkehr, et al.
Respiratory Research (2025) Vol. 26, Iss. 1
Open Access
Therapeutic implications of ongoing alveolar viral replication in COVID-19
Dennis McGonagle, Mary F. Kearney, Anthony O’Regan, et al.
The Lancet Rheumatology (2021) Vol. 4, Iss. 2, pp. e135-e144
Open Access | Times Cited: 23
Kinetics of IL-6, C-reactive Protein and Fibrinogen Levels in COVID-19 Outpatients Who Evolved to Hypoxemia
Sérgio Paulo de Mello Mendes-Filho, Rebeca de Souza Pinheiro, Fernanda Simão Martins, et al.
Clinical Pathology (2024) Vol. 17
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top